Advanced Filters
noise

Osteoporosis Clinical Trials

A listing of Osteoporosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 116 clinical trials

Immunophenotyping in Patients With Osteoporosis

In addition to a medical history and clinical examination, the diagnosis of osteoporosis includes the measurement of bone surface density by means of dual X-ray absorptiometry (DXA). In addition, blood tests are performed for certain parameters, such as vitamin D, calcium, phosphate and C-reactive protein. In order to optimize osteoporosis …

18 years of age All Phase N/A
B Büşra Şirin

Orthorexia Nervosa in Postmenopausal Osteoporosis

A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without osteoporosis, will be included in our study. Sociodemographic data such as age, sex, height, weight, and BMI will be recorded. Additionally, information …

55 - 75 years of age Female Phase N/A
A Ayşe Güldem Kilciler, Prof. Dr.

Health Literacy and Osteoporosis Awareness

Osteoporosis (OP) is defined as a progressive metabolic bone disease characterized by low bone mass and deterioration of the microarchitecture of bone tissue, resulting in increased bone fragility and a higher risk of fractures. Osteoporosis and related fractures constitute a significant public health problem in our increasingly aging world. It …

65 years of age All Phase N/A
A Ashley Keller

Markers of Osteoporosis in Cystic Fibrosis

Main Study Up to 100 subjects, both non-CF volunteers and Cystic Fibrosis (CF) patients, will participate in a single study visit that will include a DEXA scan, micro CT, and blood collection. Denosumab (Prolia) Sub study Approximately 10 adult subjects with CF who participated in the main study and have …

18 - 64 years of age All Phase 4

Preserving Geriatric Muscle With an Osteoporosis Medication

Our goal is to demonstrate efficacy of the novel agent Denosumab to improve or preserve muscle health, strength, mobility and function in frail older adults.

65 years of age All Phase 4
H Helge E Lundberg, MD

Profylactic Treatment for Patients in Risk Osteoporosis

The aim is to compare the daily intake of Calsium (Ca) + vitamin D with and without daily optimal efficacy dose (OED) of Jarlsberg on Bone Mineral Density (BMD) and bone markers (BM) to Osteopeni patients (OP). The study population consists of OP-patients of post-menopausal women and men above 55 …

55 - 85 years of age All Phase N/A
B Bilal UYSAL, assistant professor

Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis

Background: Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory rheumatological disease. Use of corticosteroids for more than 3 months in RA treatment is considered an important risk factor in terms of developing secondary osteoporosis and increasing the risk of fracture. The cumulative effect of taking one or more drugs with …

18 years of age All Phase N/A
S Songul B Yentur

Investigation of Q Angle in Osteoporosis Patients

Osteoporosis (OP) is a bone disease characterized by reduced bone density and deterioration of bone tissue, leading to an increased risk of fractures. There are no studies evaluating Q angle in patients with OP and Osteopenia (OPN) in the literature. Therefore, the aim of this study was to examine the …

18 - 65 years of age Female Phase N/A
A Anne Heaven, MPhil

Primary Care Management of Osteoporosis in Older Women

The Investigators aim to improve primary-care for older women with osteoporosis. Older women they spoke with previously felt unseen, unimportant, unheard and uninformed. These women felt that bone/joint health was an important issue for women aged 70+. Osteoporosis is a disease that makes bones more breakable and can lead to …

70 years of age All Phase N/A
B Büşra Şirin

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis

The primary aim of our study is to evaluate the presence of stress urinary incontinence in postmenopausal patients with and without osteoporosis, determine its impact on quality of life, and explore its relationship with sarcopenia.

50 - 75 years of age Female Phase N/A

Simplify language using AI